Otsuka Pakistan Limited (PSX: OTSU)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
133.91
+2.01 (1.52%)
At close: Sep 9, 2024

Otsuka Pakistan Company Description

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.

The company’s products include electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products, such as aminoleban oral, proten gold, pan-amin G, aminoleban injection, and aminovel 600; and therapeutic drugs, which include mucosta tablets and pletaal, as well as oral rehydration therapy.

It also engages in the trading of pharmaceutical products, nutritional foods, and medical equipment. Further, the company offers Made in Germany CE-marked drug-eluting coronary stents, PTCA balloon catheters, and other coronary angioplasty accessories and electrophysiology products.

The company was incorporated in 1988 and is headquartered in Karachi, Pakistan.

Otsuka Pakistan Limited
Country Pakistan
Founded 1988
Industry Pharmaceuticals
Sector Healthcare
Employees 362
CEO Moin-ur Rehman

Contact Details

Address:
30-B, Sindhi Muslim Co-operative Housing Society
Karachi, 74400
Pakistan
Phone 92 21 3452 8651
Website otsuka.pk

Stock Details

Ticker Symbol OTSU
Exchange Pakistan Stock Exchange
Fiscal Year July - June
Reporting Currency PKR
ISIN Number PK0038001019
SIC Code 2834

Key Executives

Name Position
Moin-ur Rehman Chief Executive Officer
Rao Sajid Khan Chief Financial Officer